Low Reporting of Cointerventions in Recent Cardiovascular Clinical Trials: A Systematic Review

Low Reporting of Cointerventions in Recent Cardiovascular Clinical Trials: A Systematic Review

Background A cointervention in a randomized clinical trial (RCT) is medical care given in addition to the tested intervention. If cointerventions are unbalanced between trial arms, the results may be biased. We hypothesized that cointerventions would be more adequately reported in RCTs without full...

Full description

Bibliographic Details
Main Authors:	Elisavet Moutzouri, Luise Adam, Martin Feller, Lamprini Syrogiannouli, Bruno R. Da Costa, Cinzia Del Giovane, Douglas C. Bauer, Drahomir Aujesky, Arnaud Chiolero, Nicolas Rodondi
Format:	Article
Language:	English
Published:	Wiley 2020-06-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	blinding cardiovascular trials cointerventions competing treatments reporting risk of bias
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.119.014890

Similar Items

Inadequate Reporting of Cointerventions, Other Methodological Factors, and Treatment Estimates in Cardiovascular Trials: A Meta-Epidemiological Study
by: Jonas Bührer, MD, et al.
Published: (2023-08-01)

Lipid‐Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta‐Analysis of Exclusion Criteria
by: Martina Aeschbacher‐Germann, et al.
Published: (2023-01-01)

Random guess and wishful thinking are the best blinding scenarios
by: Heejung Bang
Published: (2016-08-01)

How to prevent overdiagnosis
by: Arnaud Chiolero, et al.
Published: (2015-01-01)

Blinding in Clinical Trials: Seeing the Big Picture
by: Thomas F. Monaghan, et al.
Published: (2021-06-01)

Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients
by: Dimitrios David Papazoglou, et al.
Published: (2021-01-01)

Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients.
by: Dimitrios David Papazoglou, et al.
Published: (2021-01-01)

Who knew? The misleading specificity of “double-blind” and what to do about it
by: Thomas A. Lang, et al.
Published: (2020-08-01)

Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment?
by: Sabrina Jegerlehner, et al.
Published: (2019-01-01)

Lipid‐Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Sylvain Bétrisey, et al.
Published: (2024-02-01)

Development and validation of a new prognostic index for mortality risk in multimorbid adults.
by: Viktoria Gastens, et al.
Published: (2022-01-01)

Large regional variation in cardiac closure procedures to prevent ischemic stroke in Switzerland a population-based small area analysis
by: Nina Stoller, et al.
Published: (2024-01-01)

Variation in regional implantation patterns of cardiac implantable electronic device in Switzerland.
by: Lucy Bolt, et al.
Published: (2022-01-01)

Unwarranted regional variation in vertebroplasty and kyphoplasty in Switzerland: A population-based small area variation analysis.
by: Claudia Scheuter, et al.
Published: (2018-01-01)

Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups? A protocol for a meta-epidemiological study of PDE-5 inhibitors
by: Feys Frederik, et al.
Published: (2012-11-01)

Regional variation and temporal trends in transcatheter and surgical aortic valve replacement in Switzerland: A population-based small area analysis.
by: Carla Schenker, et al.
Published: (2024-01-01)

High regional variation in prostate surgery for benign prostatic hyperplasia in Switzerland.
by: Maria M Wertli, et al.
Published: (2021-01-01)

Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study.
by: Sabrina Jegerlehner, et al.
Published: (2017-01-01)

Is there a shift from cardiovascular to cancer death in lipid-lowering trials? A systematic review and meta-analysis
by: Lucy Bolt, et al.
Published: (2024-01-01)

Is there a shift from cardiovascular to cancer death in lipid-lowering trials? A systematic review and meta-analysis.
by: Lucy Bolt, et al.
Published: (2024-01-01)

Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: pitfalls and potential
by: Oksana Martinuka, et al.
Published: (2024-03-01)

Regional variation of hysterectomy for benign uterine diseases in Switzerland.
by: Nina Stoller, et al.
Published: (2020-01-01)

CONSORT 2010 and Controversies Regarding Assessment of Blindness in RCTs
by: Norman A. Desbiens, et al.
Published: (2010-11-01)

Assessment of blinding success among dental implant clinical trials: A systematic review
by: Jafar Kolahi, et al.
Published: (2015-01-01)

Agency and self-other asymmetries in perceived bias and shortcomings: Replications of the Bias Blind Spot and link to free will beliefs
by: Subramanya Prasad Chandrashekar, et al.
Published: (2021-11-01)

Agency and self-other asymmetries in perceived bias and shortcomings: Replications of the Bias Blind Spot and link to free will beliefs
by: Subramanya Prasad Chandrashekar, et al.
Published: (2021-11-01)

Why COVID-19 trials should be blinded (as any other one)
by: Rafael Leite Pacheco, et al.
Published: (2020-04-01)

The Trade-off between Impartiality and Freedom in the 21st Century Cures Act
by: David Fraile Navarro, et al.
Published: (2021-05-01)

Assessment of blinding in randomized controlled trials of antidepressants for depressive disorders 2000–2020: A systematic review and meta-analysis
by: Yi-Hsuan Lin, et al.
Published: (2022-08-01)

Methodology series module 4: Clinical trials
by: Maninder Singh Setia
Published: (2016-01-01)

Prevalence and factors associated with chronic use of levothyroxine: A cohort study.
by: Camilla Janett-Pellegri, et al.
Published: (2021-01-01)

The unblinding of statisticians in clinical trials: commentary on Iflaifel et al., Trials 2023
by: Richard A. Parker
Published: (2023-09-01)

Regional variation in hip and knee arthroplasty rates in Switzerland: A population-based small area analysis.
by: Maria M Wertli, et al.
Published: (2020-01-01)

Screening and Surveillance Bias in Cancer
by: Stefano Tancredi, et al.
Published: (2023-03-01)

Assessing the risk of bias in randomized controlled trials in the field of dentistry indexed in the Lilacs (Literatura Latino-Americana e do Caribe em Ciências da Saúde) database
by: Christiane Alves Ferreira, et al.

Emotion Induced Blindness Is More Sensitive to Changes in Arousal As Compared to Valence of the Emotional Distractor
by: Divita Singh, et al.
Published: (2017-08-01)

Specific-class Skin Side-effects of Drugs Might Compromise Blinding in Randomized Controlled Trials
by: Giao Do-Pham, et al.
Published: (2023-02-01)

Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial
by: Veerus Piret, et al.
Published: (2012-04-01)

An evaluation of the quality of published clinical trials in Iranian medical journals during 2001-04
by: MT Ayatollahi, et al.
Published: (2005-10-01)

Antiaging efficacy of melatonin-based day and night creams: a randomized, split-face, assessor-blinded proof-of-concept trial
by: Milani M, et al.
Published: (2018-01-01)